Latest News and Press Releases
Want to stay updated on the latest news?
-
BEIJING, July 16, 2026 (GLOBE NEWSWIRE) -- InnoCare Pharma (HKEX: 09969; SSE: 688428), a leading biopharmaceutical company focusing on the treatment of cancer and autoimmune diseases, announced...
-
CONSHOHOCKEN, Pa., July 16, 2026 (GLOBE NEWSWIRE) -- Madrigal Pharmaceuticals, Inc. (Nasdaq: MDGL) announced today that it will release its second-quarter 2026 financial results on Thursday, July...
-
Dyadic Expands Bio industrial Pipeline with New Proprietary Industrial Enzyme Program
-
Persephoni Backs SelSym Biotech to Bring Blood-Type-Agnostic Bleeding Control to the Point of Injury
Persephoni backs SelSym Biotech to bring the first shelf-stable, blood-type agnostic hemostatic therapy to the point of injury, expanding trauma access.
-
aTyr Pharma to Present Subgroup Analysis of Phase 3 EFZO-FIT™ Study of Efzofitimod in Pulmonary Sarcoidosis at WASOG 2026
-
De solides résultats financiers au troisième trimestre : 31,8 millions de dollars en produits totaux, déduction faite des taxes d’accise, une marge brute avant ajustements de la juste valeur de 13,4...
-
Cannara reports record Q3 2026 revenue, continued profitability, broader national distribution and accelerated capacity expansion to meet growing demand.
-
BEIJING, July 15, 2026 (GLOBE NEWSWIRE) -- InnoCare Pharma (HKEX: 09969; SSE: 688428), a leading biopharmaceutical company focusing on the treatment of cancer and autoimmune diseases, announced...
-
Lira Clinical is proud to announce the launch of its groundbreaking new REGEN PDRN+ skincare line with Wild Salmon Stem Cell–Conditioned Media.
-
Genopore appoints Rey Mali as CEO to accelerate growth of its AI-powered optical nanopore platform for single-molecule protein identification.